Buscar
Itens para a visualização no momento 1-10 of 11
Preprint
Apixaban, an orally available anticoagulant, inhibits SARS-CoV-2 replication and its major protease in a non-competitive way
| Data do documento:
2022 | Direito Autoral:
open access
Preprint
The role of NSP6 in the biogenesis of the SARS-CoV-2 replication organelle
| Data do documento:
2022 | Direito Autoral:
open access
Preprint
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential Mechanisms - Short running title: Ebola SARS-CoV-2 inhibitors
| Data do documento:
2021 | Direito Autoral:
open access
Preprint
Non-permissive SARS-CoV-2 infection of neural cells in the developing human brain and neurospheres
| Data do documento:
2020 | Direito Autoral:
open access
Preprint
Non-permissive SARS-CoV-2 infection in human neurospheres (preprint)
| Data do documento:
2021 | Direito Autoral:
open access
Preprint
Atazanavir inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production
| Data do documento:
2020 | Direito Autoral:
open access
Preprint
The COVID-19 pandemics and the relevance of biosafety facilities for metagenomics surveillance, structured disease prevention and control
| Data do documento:
2020 | Direito Autoral:
open access
Preprint
Human endogenous retrovirus K activation in the lower respiratory tract of severe COVID-19 patients associates with early mortality
| Data do documento:
2021 | Direito Autoral:
open access
Preprint
Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production
| Data do documento:
2020 | Direito Autoral:
open access
Preprint
Combination of Antiviral Drugs to Inhibit SARS-CoV-2 Polymerase and Exonuclease as Potential COVID-19 Therapeutics
| Data do documento:
2021 | Direito Autoral:
open access